First patient treated in therapeutic prostate cancer trial
Filed with ASX · · 3 pages · English
Clarity Pharmaceuticals Ltd. on 6ix
Earlier from Clarity Pharmaceuticals
- First participant imaged in Phase II SAR-Bombesin trial
- First participants imaged in SAR-Bombesin trial
- Recruitment opens for Phase II trial in Prostate Cancer
- Paediatric neuroblastoma trial advances to cohort 3
- Imaging trial in prostate cancer opens for recruitment
Later from Clarity Pharmaceuticals
- 50% recruitment milestone reached for prostate cancer trial
- Corporate Presentation - Wilsons Drug and Device Conference
- 50% recruitment reached for Phase II prostate cancer trial
- Clarity Presentation -Bell Potter Healthcare Conference 2022
- IND approval from the FDA for theranostic SAR-Bombesin trial
Follow Clarity Pharmaceuticals into a list and get an email when it puts out news.
Follow Clarity Pharmaceuticals